Other than promoting cell proliferation, the activation of tumorigenic Myc during hepatocarcinogenesis also causes changes in the tumor microenvironment by interacting with hypoxia-inducible factor-1 alpha (HIF-1α) and HIF-2α to increase angiogenesis4, 5. Here, MYC is linked to neoplasm.